[StAnDeliver]

Prof. Raoult has done it. The French have a treatment. Raoult has eliminated the control group, and opened the trial to all.

Cuomo is going to run Raoult's protocols starting Tuesday in New York disguised as a 'massive trial' -- it's no trial, it's the actual treatment!

The FDA using Regeneron labs in New York, will provide Cuomo with 10,000 PQL+AZT units -- unironically nearly equal to the amount of cases in New York.

TEVA Pharms makes generics of both PQL and AZT and is donating 6 million doses to US starting now to the end of March. Azithromycin is not in short supply, and is not particularly hard to make (Israeli firm TEVA Pharms makes a generic of AZT too, as do about 10 other companies).

The French won the battle and maybe the war. Vive Didier Raoult! Vive La France!

[ProtectOurFreedom]

Just WOW on PLQ + AZT. Incredible.

Can we lift the “shelter in place” order now?

[House Atreides]

Doctor Fauci and the bureaucratic CDC DO NOT APPROVE! ;-)

Props to these French doctors.

[be-baw]

Great post. I’ve seen a lot of good articles lately, but yours is the best I’ve seen in a long time.

Thanks

[Yaelle]

Pas mal ça!

[headstamp 2]

Trials in the field. They’ll get a huge amount of data and save lives.

[House Atreides]

“...TEVA Pharms makes generics of both PQL and AZT and is donating 6 million doses to US starting now to the end of March. Azithromycin is not in short supply, and is not particularly hard to make (Israeli firm TEVA Pharms makes a generic of AZT too, as do about 10 other companies)....”
***********************************
Mylan is reopening a shuttered West Virginia manufacturing facility and expects delivery of product beginning in early April. I’m pretty sure the facility is in Morgantown WV. They have necessary “raw materials” on hand for 50 million tabs. This is important because of the possibility of supply constraints on precursor stock.

http://newsroom.mylan.com/2020-03-19-Mylan-Ramps-Up-U-S-Manufacturing-of-Hydroxychloroquine-Sulfate-Tablets-to-Meet-Potential-COVID-19-Patient-Needs

I believe there are 7 to 8 CURRENT manufacturers of Hydroxychloroquine and more gearing up to manufacture.

[Bigg Red]

Very good.Thanks for posting this.

[catnipman]

“TEVA Pharms makes generics of both PQL and AZT and is donating 6 million doses to US starting now to the end of March. Azithromycin is not in short supply, and is not particularly hard to make (Israeli firm TEVA Pharms makes a generic of AZT too, as do about 10 other companies).”

i appreciate you posting this information; i felt like a lone voice in the wilderness trying to cut through all of the noise of FR ignorance trying to post information like that ...

[Orosius]

I wish FR had a Like button. You’d get ten thousand of them, and that’s just from me!

[allendale]

The Wusan triad is Fever, Cough and Shortness of Breath. It is now considered diagnostic of COVID-19 infection by the New York City Board of Health. If a patient has Fever and Cough, then the this therapeutic regimen should start before the third point of the triad ,Shortness of Breath, is reached. By then the lungs have already been compromised and the clinical outcome is in doubt. People are concerned that the quinolones and Zithromax prolong the QT interval on EKG and this may lead to serious or fatal arrhythmias. Many therapeutic agents prolong the QT interval. However if a person develops a pneumonia the right side pressures of the heart increase rapidly and while myocardial tissue itself is not a direct target of the virus, the increased strain on the heart due to hypoxemia and increased pressures can in itself lead to arrhythmias.

Quinolones and Zithromax may or may not work. However as of now its the best physicians can offer to patients ill with COVID-19. RNA viruses are bad actors and developing a vaccine is difficult. However until an effective and safe vaccine is developed, this virus will continue to devastate humans and their culture.

BTW believe data out of China at your own risk.

[StAnDeliver]

Merci, Professeur.

Professeur Didier Raoult, director of the Research Unit in Infectious and Tropical Emergent Diseases,
IHU Méditerranée Infection, Aix-Marseille University |Photo by Julien Poupart/ABACAPRESS.COM

[ding_dong_daddy_from_dumas]

PQL? PLQ? what do they mean?

[ProtectOurFreedom]

The University of Minnesota is launching a clinical trial on a post-exposure treatment for coronavirus COVID-19 disease. They are recruiting test subjects.

COVID-19 Clinical Trial Launches at University of Minnesota
by Kelly Glynn, Media Relations Coordinator March 17, 2020

If you think you may be eligible to participate in the trial, please email covid19@umn.edu for further instructions.

The trial is being limited to only high-risk exposures, so that the trial may be completed as quickly as possible with the fewest number of volunteers. At this time, people who may have been exposed to coronavirus in the community are currently not eligible to participate.

[Chaguito]

The announcement does not make this an official protocol for all of France, just for this institute/hospital. Or am I missing something?

[Hoosier-Daddy]

BTTT

[Steve_Seattle]

I don’t know how large their sample was, but it looks like the two drugs together have about a 95-97% cure rate.

[StAnDeliver]

How is not ExtendedNews, if not BreakingNews?

Was it reported as too difficult to understand? Perhaps too much French? Too many numbers? Multi-syllable words?

Cuomo is going to unleash this treatment on Tuesday ... would you rather wait for FoxNews to put out 5 grafs of short junk with the requisite grammatical errors?

[guitar Josh]

Hope this works

[eartick]

WAIT A MINUTE....this has not been approved by Dr. Farci.

[Chauncey Gardiner]

Glad Dr Fauxi was not in today’s briefing. He stands in the way of treatment protecting his turf and his Big Pharma buddies.